Research programme: epimorphin-derived peptide - Sumitomo Electric

Drug Profile

Research programme: epimorphin-derived peptide - Sumitomo Electric

Alternative Names: Epimorphin-derived peptide - Sumitomo Electric; Epimorphin-derived peptide research programme - Sumitomo Electric; EPM; pep 7

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sumitomo Electric Industries
  • Class Peptides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alopecia

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Alopecia in Japan (Topical)
  • 31 Aug 2005 This programme is still in active development for Alopecia
  • 31 Aug 2005 A preclinical study has been added to the pharmacokinetics and Skin Disorders pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top